UK markets open in 1 hour 6 minutes

Axonics, Inc. (AXNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
66.87+0.30 (+0.45%)
At close: 04:00PM EDT
66.87 0.00 (0.00%)
After hours: 04:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close66.57
Open66.50
Bid47.74 x 200
Ask85.33 x 200
Day's range66.39 - 67.09
52-week range47.59 - 69.68
Volume730,540
Avg. volume861,967
Market cap3.412B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.31
Earnings date25 Jul 2024 - 29 Jul 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est71.73
  • Business Wire

    Axonics Reports First Quarter 2024 Financial Results

    IRVINE, Calif., April 30, 2024--Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial results for the three months ended March 31, 2024.

  • PR Newswire

    Boston Scientific Announces Results for First Quarter 2024

    Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $495 million or $0.33 per share (EPS), compared to $300 million or $0.21 per share a year ago, and achieved adjusted3 EPS of $0.56 for

  • Zacks

    All You Need to Know About Axonics (AXNX) Rating Upgrade to Buy

    Axonics (AXNX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).